New drug trial offers hope for tough blood cancers
Disease control
Recruiting now
This study is testing a new drug called CTX-712 for adults whose acute myeloid leukemia or myelodysplastic syndromes have returned or not responded to prior treatments. The main goals are to find a safe and effective dose and to see if the drug can help put the cancer into remiss…
Phase: PHASE1, PHASE2 • Sponsor: Chordia Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC